Matches in Wikidata for { <http://www.wikidata.org/entity/Q65390578> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65390578 description "clinical trial" @default.
- Q65390578 description "ensayu clínicu" @default.
- Q65390578 description "klinisch onderzoek" @default.
- Q65390578 description "клінічне випробування" @default.
- Q65390578 name "SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration" @default.
- Q65390578 name "SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration" @default.
- Q65390578 type Item @default.
- Q65390578 label "SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration" @default.
- Q65390578 label "SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration" @default.
- Q65390578 prefLabel "SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration" @default.
- Q65390578 prefLabel "SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration" @default.
- Q65390578 P1050 Q65390578-78662565-6B6D-405C-90C4-F39F8F3B65D3 @default.
- Q65390578 P1132 Q65390578-5ACCA5E9-06A1-4ED0-9B9D-A0B81EE59753 @default.
- Q65390578 P1476 Q65390578-5705A161-A842-43F6-A682-67245A04BB4A @default.
- Q65390578 P17 Q65390578-7DE538FD-EA5D-4650-AB63-23312DC240F9 @default.
- Q65390578 P2899 Q65390578-74AE0A6F-82F4-4DEF-9E47-B32D54E49737 @default.
- Q65390578 P3098 Q65390578-17899051-530F-49A0-994A-81B384E16C8A @default.
- Q65390578 P31 Q65390578-6745F116-3CEC-46B2-AB1F-D8A6BF9751D9 @default.
- Q65390578 P4844 Q65390578-6233D062-616C-40CE-86FB-3D1FE1D4D590 @default.
- Q65390578 P580 Q65390578-690CF067-191C-4E59-8962-12FBC41A13CA @default.
- Q65390578 P582 Q65390578-D09D7353-CA9D-4752-A5C5-6D4723560F9F @default.
- Q65390578 P6099 Q65390578-06892FD2-0BC7-43A5-B8CD-7A4327207464 @default.
- Q65390578 P8363 Q65390578-CABB5511-9E1E-4938-BD8F-1DCD7D0CC067 @default.
- Q65390578 P1050 Q27429789 @default.
- Q65390578 P1132 "+531" @default.
- Q65390578 P1476 "A Phase IIIb, Open-label, Multi-center 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of Ranibizumab (0.3 mg and/or 0.5 mg) in Patients With Subfoveal Choroidal Neovasculariza-tion Secondary to Age-related Macular Degeneration" @default.
- Q65390578 P17 Q39 @default.
- Q65390578 P2899 "+50" @default.
- Q65390578 P3098 "NCT00331864" @default.
- Q65390578 P31 Q30612 @default.
- Q65390578 P4844 Q414270 @default.
- Q65390578 P580 "2006-04-01T00:00:00Z" @default.
- Q65390578 P582 "2008-04-01T00:00:00Z" @default.
- Q65390578 P6099 Q42824827 @default.
- Q65390578 P8363 Q78089383 @default.